Chemotherapy-free regimens in frontline follicular lymphoma

被引：0
作者：
Batlevi, Connie Lee [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
BLOOD | 2022年 / 139卷 / 15期
关键词：
LENALIDOMIDE;
D O I：
10.1182/blood.2021015120
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Lenalidomide and anti-CD20-based combinations have validated efficacy in treatment of follicular lymphoma in both the frontline and the relapsed settings. In this issue of Blood, Bachy et al(1) report the tolerability and efficacy of obinutuzumab and lenalidomide in the frontline therapy of follicular lymphoma.
引用
收藏
页码：2263 / 2264
页数：3
相关论文
共 50 条
  • [41] Frontline treatment approaches in TP53-aberrant mantle cell lymphoma
    Shah, Nikesh N.
    Castillo-Tokumori, Franco
    Whiting, Junmin
    Boulware, David
    Sandoval-Sus, Jose
    Knepper, Todd C.
    Hussaini, Mohammad
    Tao, Jianguo
    Chavez, Julio C.
    Isenalumhe, Leidy
    Gaballa, Sameh
    Saeed, Hayder
    Bello, Celeste
    Sokol, Lubomir
    Pinilla-Ibarz, Javier
    Shah, Bijal D.
    LEUKEMIA & LYMPHOMA, 2023, 64 (01) : 230 - 233
  • [42] Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy
    Menter, Thomas
    Tzankov, Alexandar
    Zucca, Emanuele
    Kimby, Eva
    Hultdin, Magnus
    Sundstrom, Christer
    Beiske, Klaus
    Cogliatti, Sergio
    Banz, Yara
    Cathomas, Gieri
    Katjalainen-Lindsberg, Marja-Liisa
    Grobholz, Rainer
    Mazzucchelli, Luca
    Sander, Birgitta
    Hawle, Hanne
    Hayoz, Stefanie
    Dirnhofer, Stefan
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (04) : 707 - 717
  • [43] Efficacy of rituximab combined with lenalidomide in patients with recurrent follicular lymphoma
    Liu, Zhaoyu
    Gao, Hong
    Peng, Qin
    Yang, Yongheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (09): : 11708 - 11715
  • [44] Advances in the treatment of high burden Follicular lymphoma: a Comprehensive review
    Luttwak, Efrat
    Kumar, Anita
    Salles, Gilles
    LEUKEMIA & LYMPHOMA, 2025, : 818 - 829
  • [45] Translational insights into the genetics and immunobiology of relapsed/ refractory follicular lymphoma
    Yaniv, Benyamin
    Tanenbaum, Benjamin
    Kazakova, Vera
    Patel, Shyam A.
    LEUKEMIA RESEARCH, 2024, 142
  • [46] Carfilzomib-based combination regimens are highly effective frontline therapies for multiple myeloma and Waldenstrom's macroglobulinemia
    Chaudhry, Maria
    Steiner, Raphael
    Claussen, Catherine
    Patel, Krina
    Lee, Hans
    Weber, Donna
    Thomas, Sheeba
    Feng, Chun
    Amini, Behrang
    Orlowski, Robert
    Feng, Lei
    Manasanch, Elisabet E.
    LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 964 - 970
  • [47] A Comparison of Salvage Infusional Chemotherapy Regimens for Recurrent/Refractory Multiple Myeloma
    Griffin, Patrick T.
    Ho, Viet Q.
    Fulp, William
    Nishihori, Taiga
    Shain, Kenneth H.
    Alsina, Melissa
    Baz, Rachid C.
    CANCER, 2015, 121 (20) : 3622 - 3630
  • [48] Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma
    Nastoupil, Loretta J.
    Chin, Collin K.
    Westin, Jason R.
    Fowler, Nathan H.
    Samaniego, Felipe
    Cheng, Xiaoyun
    Ma, Man Chun John
    Wang, Zhiqiang
    Chu, Fuliang
    Dsouza, Ly
    Obi, Chizobam
    Mims, Jennifer
    Feng, Lei
    Zhou, Shouhao
    Green, Michael
    Davis, Richard Eric
    Neelapu, Sattva S.
    BLOOD ADVANCES, 2022, 6 (04) : 1143 - 1151
  • [49] Radiologic and molecular remission of follicular T cell lymphoma treated with lenalidomide
    Yok-Lam Kwong
    Annals of Hematology, 2017, 96 : 513 - 515
  • [50] Treatment of indolent lymphoma without chemotherapy: hype or hope?
    Viardot, Andreas
    Hess, Georg
    ONKOLOGE, 2019, 25 (10): : 859 - 866
12345